Back to Journals » International Journal of Nanomedicine » Volume 8 » Issue 1

Development of a novel niosomal system for oral delivery of Ginkgo biloba extract

Authors Jin Y, Wen J, Garg S, Liu D, Zhou Y, Teng L, Zhang W

Received 11 September 2012

Accepted for publication 6 November 2012

Published 24 January 2013 Volume 2013:8(1) Pages 421—430


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Ye Jin,1,4 Jingyuan Wen,2 Sanjay Garg,3 Da Liu,1 Yulin Zhou,1 Lirong Teng,1,* Weiyu Zhang,4,*

College of Life Science, Jilin University, Jilin, People’s Republic of China; 2School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; 3School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia; 4School of Pharmacy, Changchun University of Chinese Medicine, Jilin, People’s Republic of China

*These authors contributed equally to this work

Background: The aim of this study was to develop an optimal niosomal system to deliver Ginkgo biloba extract (GbE) with improved oral bioavailability and to replace the conventional GbE tablets.
Methods: In this study, the film dispersion-homogenization method was used to prepare GbE niosomes. The resulting GbE niosome suspension was freeze-dried or spray-dried to improve the stability of the niosomes. GbE-loaded niosomes were formulated and characterized in terms of their morphology, particle size, zeta potential, entrapment efficiency, and angle of repose, and differential scanning calorimetry analysis was performed. In vitro release and in vivo distribution studies were also carried out.
Results: The particle size of the optimal delivery system prepared with Tween 80, Span 80, and cholesterol was about 141 nm. There was a significant difference (P < 0.05) in drug entrapment efficiency between the spray-drying method (about 77.5%) and the freeze-drying method (about 50.1%). The stability study revealed no significant change in drug entrapment efficiency for the GbE niosomes at 4°C and 25°C after 3 months. The in vitro release study suggested that GbE niosomes can prolong the release of flavonoid glycosides in phosphate-buffered solution (pH 6.8) for up to 48 hours. The in vivo distribution study showed that the flavonoid glycoside content in the heart, lung, kidney, brain, and blood of rats treated with the GbE niosome carrier system was greater than in the rats treated with the oral GbE tablet (P < 0.01). No flavonoid glycosides were detected in the brain tissue of rats given the oral GbE tablets, but they were detected in the brain tissue of rats given the GbE niosomes.
Conclusion: Niosomes are a promising oral system for delivery of GbE to the brain.

Keywords: Ginkgo biloba extract, flavonoid glycosides, niosomes, oral delivery, in vivo distribution

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]